Newsletter | Healthcare & Life Sciences 29/07/2025

On June 4, 2025, the European Parliament's Committee on the Environment, Public Health, and Food Safety (ENVI) formally adopted its negotiating position on the “Pharma Package.” The Council of the European Union has already expressed its willingness to start interinstitutional negotiations, highlighting the strategic value of this reform for the governance of medicine in the European single market. 

In the latest newsletter, Chiomenti professionals analyzed the main innovations introduced by the Council's negotiating mandate and the future prospects, emphasizing how essential it is for companies in the sector to assess the adequacy of their regulatory and research and development strategies in view of the implementation of the new regulatory framework.